Insmed stock blasts off over lung condition study results [Yahoo! Finance]
Insmed Incorporated (INSM)
Last insmed incorporated earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Yahoo! Finance
Market Domination Hosts Julie Hyman and Josh Lipton monitor Insmed's soaring stock price as it hopes to develop a range of use cases for a multitude of diseases. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan Video Transcript In SMED. This is not what we talk about frequently. It's a biotech company that announced positive results from a study of a drug to treat a rare lung condition that is called bronchi stasis. Much better. I'm glad you took a swing at that one. So basically this is a lung inflammation and it affects, you know, not a huge amount of people but enough that analysts are very, very positive after seeing results of this study. Yeah, I was really just in terms of Thailand Julie company apparently plans to file for us market clearance in the final quarter of the year, then launch in mid 20 tw 25 followed by launches in Europe and Japan. I,
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed Incorporated news events
Weekly update
A roundup of the hottest topics
INSM
News
- Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Evercore ISI from $42.00 to $75.00. They now have an "outperform" rating on the stock.MarketBeat
- Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $55.00 to $72.00. They now have an "overweight" rating on the stock.MarketBeat
- Non-cystic Fibrosis Bronchiectasis Drug Pipeline Market 2024 Featuring Zambon, AstraZeneca, Insmed, NovaBiotics, Haisco Pharmaceutical, Armata Pharmaceuticals, Chiesi Farmaceutici, & CSL Behring [Yahoo! Finance]Yahoo! Finance
- Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Mizuho from $36.00 to $82.00. They now have a "buy" rating on the stock.MarketBeat
INSM
Earnings
- 5/9/24 - Beat
INSM
Sec Filings
- 6/13/24 - Form 8-K
- 6/12/24 - Form 4
- 6/5/24 - Form 4
- INSM's page on the SEC website